Company Active LTD

Company profile

Invitron Limited

Home - Invitron

Molecular Light Technology, acridinium ester chemiluminescence detection system used in high sensitivity medical diangnostic tests.

CRN
05644115
Founded
2005
Age
20

Overview

Legal name
INVITRON LIMITED
Region
Wales
Registered address
WYASTONE BUSINESS PARK
WYASTONE LEYS
MONMOUTH
MON
NP25 3SR
Insolvency history
No

Latest accounts

Financial period: 1 Apr 2024 to 31 Mar 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
5

Company events

Reference milestones and recent Companies House filing stream events.

5 events
31 Dec
2026

Accounts due

Accounts Due

Next accounts due date

19 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

05 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Mar
2025

Accounts filed

Accounts

Last accounts made up date

05 Dec
2005

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2015
Funded years
2015, 2017, 2023
Age at first award
9 years

Projects

2023 Collaborative R&D Lead participant

A portable diagnostic device that provides the accuracy of laboratory testing at the point of care.

1 Oct 2023 to 31 Mar 2025

Awarded
£391,152
Total cost £558,789

Most of us have experienced the anxious wait for laboratory test results. Whether it's a Covid-19 test completed before travel or a blood test carried out by our doctor, laboratory turn-around times can significantly impact on everyday life. For people living with chronic diseases like diabetes this stressful delay is not only more frequent but can hinder...

2017 Collaborative R&D Lead participant

High Sensitivity Chemiluminescent Point of Care Tests for Cardiac Troponin

1 Feb 2017 to 31 Mar 2019

Awarded
£443,550
Total cost £633,643

Point of care (POC) tests are rapid medical diagnostic tests designed to be carried out next to the patient. POC devices produce results much faster than laboratory tests which enable physicians and nurses to act sooner and thus save lives, improve patient outcomes and reduce overall costs to the healthcare system. However, more widespread use of POC test...

2015 Launchpad Lead participant

Chemiluminescent Point of Care Tests

1 Jul 2015 to 31 Dec 2016

Awarded
£86,163
Total cost £143,605

Point of care tests (POCT) are rapid medical diagnostic tests designed to be carried out next to the patient. POCT devices produce results much faster than laboratory tests which enable physicians and nurses to act sooner and thus save lives, improve patient outcomes and reduce overall costs to the healthcare system. However, more widespread use of POCT i...

Product types

Collaborative R&D Launchpad